AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23742175 — intervention group
Group type: EXPERIMENTAL
Intervention: Low work surface heights (WSH)
Number of subjects: 0
Study 23742175 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher work surface heights (WSH)
Number of subjects: 0
Study 23742175 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory workbench at pipette-tip level in standing position with hand at elbow height
Number of subjects: 0
Study 23742175 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated posture during pipetting
Number of subjects: 0
Study 21495078 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (24 forms simplified)
Number of subjects: 389
Study 21495078 — intervention group
Group type: COMPARATOR
Intervention: Stretching and toning exercise (Control)
Number of subjects: 389
Study 18077730 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir 400 mg every 12 hours for 14 days
Number of subjects: 2
Study 18077730 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 2.0 mg
Number of subjects: 2
Study 16527008 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic repair using a transantral approach
Number of subjects: 9
Study 16527008 — intervention group
Group type: COMPARATOR
Intervention: Transconjunctival repair
Number of subjects: 9
Study 16527008 — intervention group
Group type: COMPARATOR
Intervention: Comparison of endoscopic repair and transconjunctival repair
Number of subjects: 9
Study 12589525 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated drink (100 mg caffeine)
Number of subjects: 48
Study 12589525 — intervention group
Group type: COMPARATOR
Intervention: Decaffeinated drink (placebo)
Number of subjects: 48
Study 10880013 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoviral vector delivered intraperitoneally (i.p.) at varying doses (2 x 10(10) to 2 x 10(13) vector particles) with concomitant topotecan chemotherapy and acyclovir.
Number of subjects: 10
Study 9083284 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid administration
Number of subjects: 12
Study 9083284 — intervention group
Group type: COMPARATOR
Intervention: Control (non-treated)
Number of subjects: 12
Study 8252937 — intervention group
Group type: EXPERIMENTAL
Intervention: Amrinone (1.5 mg/kg loading dose plus 10 micrograms/kg/min maintenance infusion; n = 20)
Number of subjects: 39
Study 8252937 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 19)
Number of subjects: 39
Study 3828182 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural infusion of 0.125% bupivacaine (Marcain) 10 ml (12.5 mg) per hour during labour
Number of subjects: 100
Study 3828182 — intervention group
Group type: COMPARATOR
Intervention: No infusion (control group)
Number of subjects: 100
Study 3828182 — intervention group
Group type: EXPERIMENTAL
Intervention: Extradural infusion of 0.125% bupivacaine (Marcain)
Number of subjects: 100
Study 29549891 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (ACP)
Number of subjects: 30
Study 29549891 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SACP)
Number of subjects: 30
Study 26538631 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine NGAL/creatinine
Number of subjects: 0
Study 26538631 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine KIM-1/creatinine
Number of subjects: 0
Study 26538631 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine IL-18/creatinine
Number of subjects: 0
Study 26538631 — intervention group
Group type: EXPERIMENTAL
Intervention: Urine L-FABP
Number of subjects: 0
Study 25262252 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced and prolonged Holter ECG monitoring (10 days at baseline and after 3 and 6 months)
Number of subjects: 400
Study 25262252 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (≥24‐hour continuous ECG monitoring)
Number of subjects: 400
Study 22959497 — intervention group
Group type: EXPERIMENTAL
Intervention: High-glycemic load diet
Number of subjects: 89
Study 22959497 — intervention group
Group type: COMPARATOR
Intervention: Low-glycemic load diet
Number of subjects: 89
Study 20014353 — intervention group
Group type: EXPERIMENTAL
Intervention: Local intervention effect
Number of subjects: 0
Study 20014353 — intervention group
Group type: COMPARATOR
Intervention: Testing group mean difference
Number of subjects: 0
Study 18199022 — intervention group
Group type: EXPERIMENTAL
Intervention: Arnica D4 10 pillules (taken orally, 3 times per day)
Number of subjects: 88
Study 18199022 — intervention group
Group type: COMPARATOR
Intervention: diclofenac sodium, 50 mg (taken orally, 3 times per day)
Number of subjects: 88
Study 18199022 — intervention group
Group type: EXPERIMENTAL
Intervention: Arnica D4
Number of subjects: 88
Study 15728371 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of transgenic potatoes (100 g of tuber, HBsAg at approximately 8.5 microg/g)
Number of subjects: 50
Study 15728371 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of transgenic potatoes (100 g of tuber, HBsAg at approximately 8.5 microg/g)
Number of subjects: 50
Study 15728371 — intervention group
Group type: COMPARATOR
Intervention: Nontransgenic potatoes (control group)
Number of subjects: 50
Study 12947369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridostigmine (30 mg orally 3 times daily for 2 days)
Number of subjects: 23
Study 10533157 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg)
Number of subjects: 107
Study 10533157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 9083869 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4 (200 mEq for the first 5 postoperative days)
Number of subjects: 50
Study 9083869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 1805974 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalline pure lactulose (Laevolac Cristalli)
Number of subjects: 40
Study 1805974 — intervention group
Group type: COMPARATOR
Intervention: Powder pure lactitol
Number of subjects: 40
Study 6649975 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Metronidazole
Number of subjects: 0
Study 6649975 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Metronidazole combined with intravenous Gentamycin
Number of subjects: 0
Study 31321427 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication cost transparency alerts for high-cost medications
Number of subjects: 1896
Study 28139972 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg twice daily
Number of subjects: 4426
Study 28139972 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 4426
Study 28139972 — intervention group
Group type: EXPERIMENTAL
Intervention: AR-C124910XX 60 mg twice daily
Number of subjects: 4426
Study 28139972 — intervention group
Group type: EXPERIMENTAL
Intervention: AR-C124910XX 90 mg twice daily
Number of subjects: 4426
Study 28139972 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic subgroups (body weight, sex, age, smoking, Japanese ethnicity)
Number of subjects: 4426
Study 28139972 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 4426
Study 26185899 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed appliances (brackets and archwires)
Number of subjects: 62
Study 26185899 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable appliances (acrylic plates and protruding springs)
Number of subjects: 62
Study 26185899 — intervention group
Group type: COMPARATOR
Intervention: Both groups (fixed and removable appliances)
Number of subjects: 62
Study 24499951 — intervention group
Group type: EXPERIMENTAL
Intervention: FTC/TDF (Tenofovir disoproxil fumarate coformulated with emtricitabine)
Number of subjects: 2499
Study 24499951 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2499
Study 22848766 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg praziquantel (PZQ)
Number of subjects: 93
Study 22848766 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg/kg praziquantel (PZQ)
Number of subjects: 93
Study 20673554 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive armodafinil 150 mg/d
Number of subjects: 257
Study 20673554 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study 19031646 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual instrumentation with stainless steel files
Number of subjects: 40
Study 19031646 — intervention group
Group type: COMPARATOR
Intervention: Mechanical instrumentation with RaCe rotary nickel‐titanium instruments
Number of subjects: 40
Study 16337461 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray 200 microg twice daily
Number of subjects: 981
Study 16337461 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray 200 microg once daily
Number of subjects: 981
Study 16337461 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 500 mg 3 times daily
Number of subjects: 981
Study 16337461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 981
Study 12520835 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous adrenaline (epinephrine)
Number of subjects: 0
Study 12520835 — intervention group
Group type: COMPARATOR
Intervention: High-dose adrenaline
Number of subjects: 0
Study 12520835 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasopressin
Number of subjects: 0
Study 9606780 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 67
Study 9606780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 7898178 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporin
Number of subjects: 128
Study 7898178 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 128
Study 2794177 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural family therapy
Number of subjects: 69
Study 2794177 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic child therapy
Number of subjects: 69
Study 2794177 — intervention group
Group type: COMPARATOR
Intervention: Recreational control condition
Number of subjects: 69
Study 117789 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 40
Study 117789 — intervention group
Group type: COMPARATOR
Intervention: Oral (Milk) feeding
Number of subjects: 40
Study 31522922 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsidized community-supported agriculture membership (weekly farm produce pickup from June to November)
Number of subjects: 128
Study 31522922 — intervention group
Group type: COMPARATOR
Intervention: Healthy eating information (control group)
Number of subjects: 128
Study 31522922 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsidized community-supported agriculture membership
Number of subjects: 128
Study 29212716 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic vaccination regimen
Number of subjects: 0
Study 29212716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25851629 — intervention group
Group type: EXPERIMENTAL
Intervention: CYT107 before chemotherapy
Number of subjects: 20
Study 25851629 — intervention group
Group type: EXPERIMENTAL
Intervention: CYT107 during chemotherapy
Number of subjects: 20
Study 25851629 — intervention group
Group type: COMPARATOR
Intervention: Placebo before chemotherapy
Number of subjects: 20
Study 25851629 — intervention group
Group type: COMPARATOR
Intervention: Placebo during chemotherapy
Number of subjects: 20
Study 25851629 — intervention group
Group type: EXPERIMENTAL
Intervention: CYT107 and Placebo
Number of subjects: 20
Study 23547623 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral carbohydrate solution (CHO) given in the evening prior to surgery and 2-3 hours before anesthesia.
Number of subjects: 60
Study 23547623 — intervention group
Group type: COMPARATOR
Intervention: Routine fasting (Control group).
Number of subjects: 60
Study 21685651 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive VR condition where participants could manipulate the VR figure.
Number of subjects: 94
Study 21685651 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive VR condition where participants observed the VR figure.
Number of subjects: 94
Study 21685651 — intervention group
Group type: COMPARATOR
Intervention: No VR exposure (control condition).
Number of subjects: 94
Study 18998190 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers (primary/most)
Number of subjects: 263
Study 18998190 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers with depressive symptoms
Number of subjects: 263
Study 18998190 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers with low social support
Number of subjects: 263
Study 18998190 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers of cardiac patients
Number of subjects: 263
Study 16430351 — intervention group
Group type: EXPERIMENTAL
Intervention: PhoenixCare intervention (intensive home‐based case management by registered nurse case managers)
Number of subjects: 192
Study 16430351 — intervention group
Group type: EXPERIMENTAL
Intervention: PhoenixCare intervention
Number of subjects: 192
Study 16430351 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual MCO care)
Number of subjects: 192
Study 15238183 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Controlled Ventilation (PCV)
Number of subjects: 50
Study 15238183 — intervention group
Group type: COMPARATOR
Intervention: Volume Controlled Ventilation (VCV)
Number of subjects: 50
Study 15238183 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PCV and VCV
Number of subjects: 50
Study 11386854 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (4-6 mg/kg) and carbidopa (0.5-1.0 mg/kg)
Number of subjects: 5
Study 11386854 — intervention group
Group type: COMPARATOR
Intervention: l-tryptophan (50-70 mg/kg)
Number of subjects: 5
Study 11386854 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (1 mg/kg)
Number of subjects: 5
Study 9219480 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelseal (gelatin‐sealed knitted Dacron prosthesis, n = 30)
Number of subjects: 60
Study 9219480 — intervention group
Group type: COMPARATOR
Intervention: Hemashield (collagen‐sealed woven Dacron prosthesis, n = 30)
Number of subjects: 60
Study 9219480 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 9219480 — intervention group
Group type: EXPERIMENTAL
Intervention: Gelseal
Number of subjects: 60
Study 8273320 — intervention group
Group type: EXPERIMENTAL
Intervention: Fleet enema
Number of subjects: 96
Study 8273320 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulcolax micro‐enema
Number of subjects: 96
Study 8273320 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulcolax suppository
Number of subjects: 96
Study 8273320 — intervention group
Group type: COMPARATOR
Intervention: No bowel preparation
Number of subjects: 96
Study 3689477 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing saturated to unsaturated fat ratio (S:U)
Number of subjects: 24
Study 3689477 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbed cholesterol from sources other than eggs
Number of subjects: 24
Study 3689477 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbed cholesterol from eating eggs
Number of subjects: 24
Study 3689477 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbed cholesterol from all sources including eggs
Number of subjects: 24
Study 3689477 — intervention group
Group type: EXPERIMENTAL
Intervention: Saturated to unsaturated fat ratio (S:U)
Number of subjects: 24
Study 29172029 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 × 20‐s sprints
Number of subjects: 36
Study 29172029 — intervention group
Group type: COMPARATOR
Intervention: 2 × 10‐s sprints
Number of subjects: 36
Study 29172029 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 26476074 — intervention group
Group type: COMPARATOR
Intervention: Brackets bonded with primer (Transbond™ MIP)
Number of subjects: 50
Study 26476074 — intervention group
Group type: EXPERIMENTAL
Intervention: Brackets bonded without primer
Number of subjects: 50
Study 26476074 — intervention group
Group type: EXPERIMENTAL
Intervention: Brackets bonded without primer in younger patients (10-13 years)
Number of subjects: 50
Study 26476074 — intervention group
Group type: COMPARATOR
Intervention: Brackets bonded with primer in younger patients (10-13 years)
Number of subjects: 50
Study 24768116 — intervention group
Group type: EXPERIMENTAL
Intervention: COP velocity
Number of subjects: 42
Study 24768116 — intervention group
Group type: EXPERIMENTAL
Intervention: Ellipse area
Number of subjects: 42
Study 24768116 — intervention group
Group type: EXPERIMENTAL
Intervention: COP measures during arm raise
Number of subjects: 42
Study 24768116 — intervention group
Group type: EXPERIMENTAL
Intervention: COP velocity and ML displacement
Number of subjects: 42
Study 22343600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-relieving suspension boot (Heelift; DM Systems Inc, Evanston, Illinois)
Number of subjects: 30
Study 22343600 — intervention group
Group type: COMPARATOR
Intervention: Intravenous bags
Number of subjects: 30
Study 18550225 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly individuals (≥ 65 years)
Number of subjects: 485
Study 18550225 — intervention group
Group type: COMPARATOR
Intervention: Survivors of SCI
Number of subjects: 485
Study 18550225 — intervention group
Group type: COMPARATOR
Intervention: Postmortem spinal cord tissue analysis
Number of subjects: 485
Study 18516889 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 15 microg x hr(‐1) in ropivacaine (group F3)
Number of subjects: 60
Study 18516889 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 0 microg x hr(‐1) in ropivacaine (group R)
Number of subjects: 60
Study 18516889 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 5 microg x hr(‐1) in ropivacaine (group F1)
Number of subjects: 60
Study 18516889 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 10 microg x hr(‐1) in ropivacaine (group F2)
Number of subjects: 60
Study 16767414 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide (0.075 mg)
Number of subjects: 12
Study 16767414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 14687346 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense tai chi (TC) exercise program
Number of subjects: 311
Study 14687346 — intervention group
Group type: COMPARATOR
Intervention: Wellness education (WE) program
Number of subjects: 311
Study 10955373 — intervention group
Group type: EXPERIMENTAL
Intervention: NK-104 2 mg/day
Number of subjects: 30
Study 10955373 — intervention group
Group type: EXPERIMENTAL
Intervention: NK-104 4 mg/day
Number of subjects: 30
Study 8617706 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day titrated to 200 mg/day
Number of subjects: 20
Study 8617706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 1345039 — intervention group
Group type: EXPERIMENTAL
Intervention: Ch (concentration of allergen eliciting a wheal of the same size as histamine)
Number of subjects: 36
Study 6708530 — intervention group
Group type: EXPERIMENTAL
Intervention: [3H]progesterone
Number of subjects: 14
Study 6708530 — intervention group
Group type: EXPERIMENTAL
Intervention: [125I]tracer
Number of subjects: 14
Study 31058607 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (AKI e‐alerts, AKI care bundle, education program)
Number of subjects: 24059
Study 31058607 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 24059
Study 28876332 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (Zn) supplementation
Number of subjects: 589
Study 28876332 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin (MV) supplementation
Number of subjects: 589
Study 26987818 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural change programme (BCP) with ongoing active reinforcement and enhanced provision of moisturising cream
Number of subjects: 35
Study 26987818 — intervention group
Group type: COMPARATOR
Intervention: Standard care with provision of an advice leaflet about optimal hand care
Number of subjects: 35
Study 26987818 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural change programme (BCP)
Number of subjects: 35
Study 24918298 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Isometric (FI) Squats
Number of subjects: 10
Study 24918298 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Half (DH) Squats
Number of subjects: 10
Study 24918298 — intervention group
Group type: COMPARATOR
Intervention: Combined Condition Data (FI and DH)
Number of subjects: 10
Study 21962986 — intervention group
Group type: EXPERIMENTAL
Intervention: Two consecutive meals
Number of subjects: 12
Study 20203096 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory training (12 hr)
Number of subjects: 265
Study 20203096 — intervention group
Group type: COMPARATOR
Intervention: Health training (12 hr)
Number of subjects: 265
Study 17476142 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative radiotherapy
Number of subjects: 0
Study 17476142 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to palliative radiotherapy
Number of subjects: 0
Study 17476142 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of radiation oncologists in palliative care
Number of subjects: 0
Study 17476142 — intervention group
Group type: EXPERIMENTAL
Intervention: National and professional society efforts
Number of subjects: 0
Study 15361263 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg fluoxetine for 8 weeks
Number of subjects: 369
Study 11832253 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-A (Anxiety)
Number of subjects: 736
Study 11832253 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-D (Depression)
Number of subjects: 736
Study 11832253 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-D
Number of subjects: 736
Study 11832253 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-D and HADS-A
Number of subjects: 736
Study 11832253 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-D item D4 (slowed down)
Number of subjects: 736
Study 11832253 — intervention group
Group type: EXPERIMENTAL
Intervention: HADS-A and MCS
Number of subjects: 736
Study 10362441 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate 50 mg once daily
Number of subjects: 264
Study 8808221 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.75 mmol/l calcium dialysate
Number of subjects: 14
Study 8808221 — intervention group
Group type: COMPARATOR
Intervention: 1.25 mmol/l calcium dialysate
Number of subjects: 14